-
Poliovirus therapy induces immune responses against cancer
europeanpharmaceuticalreview
September 22, 2017
Investigational therapy directly kills tumour cells and unmasks them to the body’s defences.
-
Australia launches national cancer programme
biospectrumasia
September 21, 2017
The program recognises that each child’s cancer is unique, so they respond differently to anticancer treatment.
-
Australian researchers develop novel therapies for cancer spread
biospectrumasia
September 14, 2017
The results from two international clinical trials proved successful in preventing the spread of disease in Stage III melanoma patients whose tumours had been surgically removed.
-
Cancer drug stimulates tripolar mode of mitosis
europeanpharmaceuticalreview
September 13, 2017
Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy, a current study has investigated the underlying mechanisms of this action…
-
Scientists discovers cancer drug that can reactivate HIV
europeanpharmaceuticalreview
August 28, 2017
A team of scientists have recently discovered how a new drug called JQ1 can reactivate latent HIV…
-
Accelerated Pharma puts the brakes on IPO
fiercebiotech
August 25, 2017
The biotech had originally planned a $17M IPO in October last year.
-
CRISPR and Massachusetts General Hospital partner to develop T-cell therapies
pharmaceutical-technology
August 25, 2017
CRISPR Therapeutics has entered a new research collaboration and licence option agreement with Massachusetts General Hospital Cancer Centre (MGHCC) to develop new T-cell therapies for cancer.
-
Choosing alternative cancer treatment doubles the risk of death: New Research
biospectrumasia
August 25, 2017
people who took alternative medicine were two and half times more likely to die within five years of diagnosis
-
Cancer Research UK launches trial to test new drug
europeanpharmaceuticalreview
August 24, 2017
A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres across the UK today…
-
Cancer Genetics acquires vivoPharm for $12 million USD
biospectrumasia
August 23, 2017
This transaction will significantly strengthen CGI's position as a premier leader for oncology discovery, in vivo and in vitro drug development and early phase clinical trial testing for biotechnology and pharmaceutical companies